193 related articles for article (PubMed ID: 20382086)
1. Tuberculosis drug development: progress, challenges, and the road ahead.
Ginsberg AM
Tuberculosis (Edinb); 2010 May; 90(3):162-7. PubMed ID: 20382086
[TBL] [Abstract][Full Text] [Related]
2. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
3. New drugs and new regimens for the treatment of tuberculosis: review of the drug development pipeline and implications for national programmes.
Lienhardt C; Vernon A; Raviglione MC
Curr Opin Pulm Med; 2010 May; 16(3):186-93. PubMed ID: 20216421
[TBL] [Abstract][Full Text] [Related]
4. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
5. Challenges, successes and hopes in the development of novel TB therapeutics.
Sacks LV; Behrman RE
Future Med Chem; 2009 Jul; 1(4):749-56. PubMed ID: 21426037
[TBL] [Abstract][Full Text] [Related]
6. Mycobacterium tuberculosis: drug resistance and future perspectives.
Riccardi G; Pasca MR; Buroni S
Future Microbiol; 2009 Jun; 4(5):597-614. PubMed ID: 19492969
[TBL] [Abstract][Full Text] [Related]
7. Emerging drugs for active tuberculosis.
Ginsberg AM
Semin Respir Crit Care Med; 2008 Oct; 29(5):552-9. PubMed ID: 18810688
[TBL] [Abstract][Full Text] [Related]
8. New tuberculosis therapeutics: a growing pipeline.
Spigelman MK
J Infect Dis; 2007 Aug; 196 Suppl 1():S28-34. PubMed ID: 17624823
[TBL] [Abstract][Full Text] [Related]
9. Toward an optimized therapy for tuberculosis? Drugs in clinical trials and in preclinical development.
Ma Z; Lienhardt C
Clin Chest Med; 2009 Dec; 30(4):755-68, ix. PubMed ID: 19925965
[TBL] [Abstract][Full Text] [Related]
10. Challenges and opportunities in developing novel drugs for TB.
Kaneko T; Cooper C; Mdluli K
Future Med Chem; 2011 Sep; 3(11):1373-400. PubMed ID: 21879843
[TBL] [Abstract][Full Text] [Related]
11. Prospects for new tuberculosis treatment in Africa.
Mwinga A; Bernard Fourie P
Trop Med Int Health; 2004 Jul; 9(7):827-32. PubMed ID: 15228494
[TBL] [Abstract][Full Text] [Related]
12. Extensively drug-resistant tuberculosis: current challenges and threats.
Jain A; Mondal R
FEMS Immunol Med Microbiol; 2008 Jul; 53(2):145-50. PubMed ID: 18479439
[TBL] [Abstract][Full Text] [Related]
13. Low rate of fluoroquinolone resistance in Mycobacterium tuberculosis isolates from northern Tanzania.
van den Boogaard J; Semvua HH; van Ingen J; Mwaigwisya S; van der Laan T; van Soolingen D; Kibiki GS; Boeree MJ; Aarnoutse RE
J Antimicrob Chemother; 2011 Aug; 66(8):1810-4. PubMed ID: 21642290
[TBL] [Abstract][Full Text] [Related]
14. Rising standards for tuberculosis drug development.
Balganesh TS; Alzari PM; Cole ST
Trends Pharmacol Sci; 2008 Nov; 29(11):576-81. PubMed ID: 18799223
[TBL] [Abstract][Full Text] [Related]
15. Which agents should we use for the treatment of multidrug-resistant Mycobacterium tuberculosis?
Di Perri G; Bonora S
J Antimicrob Chemother; 2004 Sep; 54(3):593-602. PubMed ID: 15282233
[TBL] [Abstract][Full Text] [Related]
16. A roadmap for drug discovery and its translation to small molecule agents in clinical development for tuberculosis treatment.
Showalter HD; Denny WA
Tuberculosis (Edinb); 2008 Aug; 88 Suppl 1():S3-17. PubMed ID: 18762151
[TBL] [Abstract][Full Text] [Related]
17. HIV infection and multidrug-resistant tuberculosis: the perfect storm.
Wells CD; Cegielski JP; Nelson LJ; Laserson KF; Holtz TH; Finlay A; Castro KG; Weyer K
J Infect Dis; 2007 Aug; 196 Suppl 1():S86-107. PubMed ID: 17624830
[TBL] [Abstract][Full Text] [Related]
18. Tuberculosis pharmacotherapy: strategies to optimize patient care.
Mitnick CD; McGee B; Peloquin CA
Expert Opin Pharmacother; 2009 Feb; 10(3):381-401. PubMed ID: 19191677
[TBL] [Abstract][Full Text] [Related]
19. Peptide deformylase--a promising therapeutic target for tuberculosis and antibacterial drug discovery.
Sharma A; Khuller GK; Sharma S
Expert Opin Ther Targets; 2009 Jul; 13(7):753-65. PubMed ID: 19530983
[TBL] [Abstract][Full Text] [Related]
20. Drug resistance in Mycobacterium tuberculosis strains isolated from re-treatment cases of pulmonary tuberculosis in Ethiopia: susceptibility to first-line and alternative drugs.
Abate G; Miörner H; Ahmed O; Hoffner SE
Int J Tuberc Lung Dis; 1998 Jul; 2(7):580-4. PubMed ID: 9661826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
